Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors
High-Dose Cisplatin, Etoposide and Bleomycin (HD-PEB) Combined With Amifostine in Children With High-Risk Malignant Germ Cell Tumors - A POG Pilot Study
3 other identifiers
interventional
27
6 countries
110
Brief Summary
RATIONALE: Chemotherapy drugs use different ways to stop tumor cells from dividing so they stop growing or die. Chemoprotective drugs such as amifostine may protect normal cells from the side effects of chemotherapy. PURPOSE: Phase I trial to study the effectiveness of high-dose cisplatin, etoposide, and bleomycin plus amifostine in treating children who have malignant germ cell tumors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2
Started Apr 2000
Longer than P75 for phase_2
110 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 1, 1999
CompletedStudy Start
First participant enrolled
April 1, 2000
CompletedFirst Posted
Study publicly available on registry
December 10, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2004
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2007
CompletedJuly 4, 2013
July 1, 2013
4.5 years
November 1, 1999
July 3, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility from Efficacy Standpoint
The hazard rate is constant over 1.39 years, then the probability of the occurrence of a failure within this time interval follows a Poisson distribution. The table below shows the trial feasibility probabilities associated with those failure rates. We define the probability of feasibility as the probability of observing a total of at most less than three failures in 25 patient years of follow-up.
Secondary Outcomes (1)
Assessment of Reduction in Toxicity
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- Children's Oncology Grouplead
- National Cancer Institute (NCI)collaborator
Study Sites (110)
University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, Alabama, 35294-3300, United States
MBCCOP - Gulf Coast
Mobile, Alabama, 36688, United States
Arizona Cancer Center
Tucson, Arizona, 85724, United States
University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205, United States
University of California San Diego Cancer Center
La Jolla, California, 92093-0658, United States
Lucile Packard Children's Hospital at Stanford
Palo Alto, California, 94304, United States
Sutter Cancer Center
Sacramento, California, 95816, United States
University of California Davis Medical Center
Sacramento, California, 95817, United States
Kaiser Permanente-Southern California Permanente Medical Group
San Diego, California, 92120, United States
Children's Hospital and Health Center
San Diego, California, 92123-4282, United States
Naval Medical Center - San Diego
San Diego, California, 92134-3202, United States
Kaiser Permanente Medical Center - Santa Clara
Santa Clara, California, 95051-5386, United States
Stanford University Medical Center
Stanford, California, 94305-5408, United States
Yale Comprehensive Cancer Center
New Haven, Connecticut, 06520-8028, United States
Walter Reed Army Medical Center
Washington D.C., District of Columbia, 20307-5000, United States
Shands Hospital and Clinics, University of Florida
Gainesville, Florida, 32610-100277, United States
Nemours Children's Clinic
Jacksonville, Florida, 32207, United States
Sylvester Cancer Center, University of Miami
Miami, Florida, 33136, United States
Miami Children's Hospital
Miami, Florida, 33155, United States
Baptist Hospital of Miami
Miami, Florida, 33176-2197, United States
Walt Disney Memorial Cancer Institute
Orlando, Florida, 32803, United States
CCOP - Florida Pediatric
Tampa, Florida, 33682-7757, United States
St. Mary's Hospital
West Palm Beach, Florida, 33407, United States
Emory University Hospital - Atlanta
Atlanta, Georgia, 30322, United States
Cancer Research Center of Hawaii
Honolulu, Hawaii, 96813, United States
Tripler Army Medical Center
Honolulu, Hawaii, 96859-5000, United States
Rush-Presbyterian-St. Luke's Medical Center
Chicago, Illinois, 60612, United States
Children's Memorial Hospital, Chicago
Chicago, Illinois, 60614, United States
Hope Children's Hospital
Oak Lawn, Illinois, 60453, United States
Saint Jude Midwest Affiliate
Peoria, Illinois, 61637, United States
University of Kansas Medical Center
Kansas City, Kansas, 66160-7357, United States
CCOP - Wichita
Wichita, Kansas, 67214-3882, United States
Via Christi Regional Medical Center
Wichita, Kansas, 67214, United States
MBCCOP - LSU Health Sciences Center
New Orleans, Louisiana, 70112, United States
Tulane University School of Medicine
New Orleans, Louisiana, 70112, United States
CCOP - Ochsner
New Orleans, Louisiana, 70121, United States
Eastern Maine Medical Center
Bangor, Maine, 04401, United States
Maine Children's Cancer Program
Portland, Maine, 04101, United States
Marlene & Stewart Greenebaum Cancer Center, University of Maryland
Baltimore, Maryland, 21201, United States
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, 21231-2410, United States
Boston Floating Hospital Infants and Children
Boston, Massachusetts, 02111, United States
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02114, United States
Dana-Farber Cancer Institute
Boston, Massachusetts, 02115, United States
University of Massachusetts Memorial Medical Center
Worcester, Massachusetts, 01655, United States
Children's Hospital of Michigan
Detroit, Michigan, 48201, United States
St. John's Hospital and Medical Center
Detroit, Michigan, 48236, United States
Hurley Medical Center
Flint, Michigan, 48503, United States
University of Mississippi Medical Center
Jackson, Mississippi, 39216-4505, United States
Keesler Medical Center - Keesler AFB
Keesler Air Force Base, Mississippi, 39534-2576, United States
University of Missouri-Columbia Hospital and Clinics
Columbia, Missouri, 65212, United States
Cardinal Glennon Children's Hospital
St Louis, Missouri, 63104, United States
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Norris Cotton Cancer Center
Lebanon, New Hampshire, 03756-0002, United States
CCOP - Northern New Jersey
Hackensack, New Jersey, 07601, United States
Hackensack University Medical Center
Hackensack, New Jersey, 07601, United States
University of New Mexico School of Medicine
Albuquerque, New Mexico, 87131, United States
Roswell Park Cancer Institute
Buffalo, New York, 14263-0001, United States
Schneider Children's Hospital
New Hyde Park, New York, 11042, United States
Mount Sinai School of Medicine
New York, New York, 10029, United States
University of Rochester Cancer Center
Rochester, New York, 14642, United States
State University of New York Health Sciences Center - Stony Brook
Stony Brook, New York, 11790-7775, United States
State University of New York - Upstate Medical University
Syracuse, New York, 13210, United States
Mission Saint Joseph's Health System
Asheville, North Carolina, 28801, United States
Carolinas Medical Center
Charlotte, North Carolina, 28232-2861, United States
Presbyterian Healthcare
Charlotte, North Carolina, 28233-3549, United States
Duke Comprehensive Cancer Center
Durham, North Carolina, 27710, United States
East Carolina University School of Medicine
Greenville, North Carolina, 27858-4354, United States
Comprehensive Cancer Center at Wake Forest University
Winston-Salem, North Carolina, 27157-1082, United States
Oklahoma Memorial Hospital
Oklahoma City, Oklahoma, 73126-0307, United States
Natalie Warren Bryant Cancer Center
Tulsa, Oklahoma, 74136, United States
CCOP - Columbia River Program
Portland, Oregon, 97213, United States
Legacy Emanuel Hospital and Health Center
Portland, Oregon, 97227, United States
St. Christopher's Hospital for Children
Philadelphia, Pennsylvania, 19134-1095, United States
Medical University of South Carolina
Charleston, South Carolina, 29425-0721, United States
Children's Hospital of Greenville Hospital System
Greenville, South Carolina, 29605, United States
James H. Quillen College of Medicine
Johnson City, Tennessee, 37614-0622, United States
Saint Jude Children's Research Hospital
Memphis, Tennessee, 38105-2794, United States
Medical City Dallas Hospital
Dallas, Texas, 75230, United States
Simmons Cancer Center - Dallas
Dallas, Texas, 75235-9154, United States
Cook Children's Medical Center - Fort Worth
Fort Worth, Texas, 76104, United States
University of Texas Medical Branch
Galveston, Texas, 77555-0209, United States
Baylor College of Medicine
Houston, Texas, 77030, United States
San Antonio Military Pediatric Cancer and Blood Disorders Center
Lackland Air Force Base, Texas, 78236-5300, United States
MBCCOP - South Texas Pediatric
San Antonio, Texas, 78229-3900, United States
University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78284-7811, United States
Scott and White Clinic
Temple, Texas, 76508, United States
Vermont Cancer Center
Burlington, Vermont, 05401-3498, United States
Cancer Center at the University of Virginia
Charlottesville, Virginia, 22908, United States
Inova Fairfax Hospital
Falls Church, Virginia, 22042-3300, United States
Naval Medical Center, Portsmouth
Portsmouth, Virginia, 23708-2197, United States
Massey Cancer Center
Richmond, Virginia, 23298-0037, United States
Carilion Roanoke Community Hospital
Roanoke, Virginia, 24029, United States
Madigan Army Medical Center
Tacoma, Washington, 98431-5000, United States
West Virginia University Medical School-Charleston
Charleston, West Virginia, 25304, United States
West Virginia University Hospitals
Morgantown, West Virginia, 26506-9300, United States
St. Vincent Hospital
Green Bay, Wisconsin, 54307-3508, United States
Midwest Children's Cancer Center
Milwaukee, Wisconsin, 53226, United States
Royal Children's Hospital
Parkville, Victoria, 3052, Australia
Alberta Children's Hospital
Calgary, Alberta, T2T 5C7, Canada
Cross Cancer Institute
Edmonton, Alberta, T6G 1Z2, Canada
Children's Hospital
Hamilton, Ontario, L8N 3Z5, Canada
Children's Hospital of Eastern Ontario
Ottawa, Ontario, K1H 8L1, Canada
Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada
McGill University Health Center - Montreal Children's Hospital
Montreal, Quebec, H3H 1P3, Canada
Hopital Sainte Justine
Montreal, Quebec, H3T 1C5, Canada
Centre Hospitalier de L'Universite Laval
Sainte-Foy, Quebec, GIV 4G2, Canada
Academisch Ziekenhuis Groningen
Groningen, 9713 EZ, Netherlands
San Jorge Childrens Hospital
Santurce, 00912, Puerto Rico
Swiss Pediatric Oncology Group Bern
Bern, CH 3010, Switzerland
Clinique de Pediatrie
Geneva, 1211, Switzerland
Related Publications (1)
Marina N, Chang KW, Malogolowkin M, London WB, Frazier AL, Womer RB, Rescorla F, Billmire DF, Davis MM, Perlman EJ, Giller R, Lauer SJ, Olson TA; Children's Oncology Group. Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children's Oncology Group study. Cancer. 2005 Aug 15;104(4):841-7. doi: 10.1002/cncr.21218.
PMID: 15999362RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Neyssa M. Marina, MD
Stanford University
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Purpose
- TREATMENT
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 1, 1999
First Posted
December 10, 2003
Study Start
April 1, 2000
Primary Completion
October 1, 2004
Study Completion
September 1, 2007
Last Updated
July 4, 2013
Record last verified: 2013-07